Emerging Markets Earnings: Astra Zeneca Lauds Surging China Sales, Keeps An Eye On Ranbaxy
This article was originally published in PharmAsia News
Executive Summary
AstraZeneca see good news out of China and no news out of India on Nexium for now – which is also good.